INSIGHTS ON SOLID DOSE MANUFACTURING

• Inline Buffer Formulation Systems

  Eliminate large storage tanks and optimize cleanroom space with automated inline buffer formulation. See how on-demand fluid handling provides precise, real-time pH and conductivity control.

• The Future Of Sustainable Amorphous Dispersion Development

  Sustainable amorphous dispersion cuts cost, risk, and timelines by removing solvent waste, simplifying manufacturing, strengthening supply chains, and scaling efficiently to commercialization.

• Tablet Logo Legibility: A Critical Component Of Consumer Health

  Optimizing tablet debossing geometry balances regulatory legibility standards with compression efficiency, preventing sticking, picking, and film coating defects.

• FastLok™ Die Table Surface Overview

  Learn about a toolless, removable surface that allows for rapid, on-turret plate replacement in minutes, not weeks, significantly improving operational efficiency.

• Benefits Of Single-Use Isolators For Cytotoxic Payload Handling

  6/15/2026

  Managing cytotoxic ADC payloads in shared containment facilities creates mounting compliance, safety, and operational costs that single-use isolator technology is designed to address.

• High Potency APIs And The Evolving Demands Of Drug Development

  4/13/2026

  See how higher API activity is changing expectations around containment, scalability, and cross‑functional alignment — and why early decisions now have a greater impact on long‑term success.

• Containment Solutions For API Weighing And Dispensing In Pharmaceutical Manufacturing

  9/30/2026

  Potency bands and exposure limits are a starting point for containment selection, not the answer. Quantity, dustiness, transfer method and process energy determine whether a control fits weighing and dispensing.

• Advancing Patient-Centric Drug Delivery For Neurodegenerative Disease With Orally Dissolving Tablets

  1/27/2025

  Pharmaceutical companies must prioritize patient-centric dosage forms to address challenges like dysphagia, enhance medication compliance, and improve therapeutic outcomes.

• Enabling Flexibility And Scientific Innovation In OSD Development

  8/31/2026

  How one clinical-stage CNS biotech navigated early formulation complexity, shifting pipeline priorities, and scalable manufacturing demands through a strategic CDMO partnership.